Alan J. Korman
Bristol-Myers Squibb (United States) · 382 works · 51,427 citations · h-index 72
Top works
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- Nivolumab plus Ipilimumab in Advanced Melanoma
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
- The class II molecules of the human and murine major histocompatibility complex
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- Expression of human class II major histocompatibility complex antigens using retrovirus vectors.
- In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
- Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- HLA‐DR Antigens: Structure, Separation of Subpopulations, Gene Cloning and Function
- cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain.
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- Checkpoint Blockade in Cancer Immunotherapy
- cDNA clones for the heavy chain of HLA-DR antigens obtained after immunopurification of polysomes by monoclonal antibody.
- Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
- The amino acid sequence and gene organization of the heavy chain of the HLA-DR antigen: homology to immunoglobulins.
- Genetic Complexity and Expression of Human Class II Histocompatibility Antigens